Author: Christian Velten

Back in 2002, I decided to contribute to and play a more active part with local affairs & politics in my home town. Over time my involvement grew by being … I continued my local political commitment until we moved close to Basel in late 2008 to start a position at Novartis. Today, I am “just” a politically interested citizen. But I still look back to the exciting times in local politics, where I learned so much and met so many dedicated people across political camps.

Between 2000 and 2008, I investigated prior art, freedom-to-operate, infringement evidences and patent portfolios for reputable patent attorneys and life science industry clients, like Roche and BASF. In 2004, I ad-hoc joined a BASF due diligence team that was preparing a company buy-in as an external expert for analyzing the biosequences portfolio (assets) of the company planned to be acquired. I locally evaluated the IP relevance of the protein and DNA sequences offered, e.g. by checking for uniqueness and redundancies. I applied in-depth computer-based sequence analysis using algorithms like BLASTx, TBLASTx, FASTA, FASTM, Smith-Waterman, and ClustalW2. CLIENT:BASFPROJECT TIME FRAME: May 2004

Following a customized market analysis, I provided Sanofi Pasteur with an online platform for continuous market monitoring. Originally Sanofi representatives asked for regular print updates of the successfully provided market analysis. I took the initiative offering a permanently updated, password-protected online portal directly giving access to all data as well as latest findings. Together with my team, I successfully set-up the platform and completed content migration within 3 weeks after approval given by the customer. CLIENT:Sanofi PasteurPROJECT TIME FRAME: April 2003

My lovely daughter Leoni Carolin Velten is born. She is the star of the whole family, we are all very proud and happy, and I got immediately addicted. A new mission, a new challenge … but such an exciting and wonderful one. Looking forward to it.

In the early 2000’s, I designed and realized one of the first German online magazines on Life Science business on behalf of GIT Publishing Ltd.. Concept and implementation included a multi-channel publishing approach. That was publishing the same content on a website (eZine), via an email-newsletter, and as WAP edition for PDAs and mobile phones (at those pre-smartphone, pre-Android and pre-iOS times the so-called Wireless Application Protocol (WAP) was the established technology for providing digital content on mobile devices). Furthermore, I set-up and managed the editorial team, workflow processes and technical infrastructure, and held editor in chief position with responsibility for sub-editors and external content providers. CLIENT:GIT…

Jan 1999 – Oct 2008 / SCITARI – DR. CHRISTIAN VELTEN INFORMATIONSDIENSTE Together with my team, I provided life science industries with digital media, editorial content, multi-channel publishing, web-based information platforms, information research, and intelligence. • Developed & implemented a multi-channel online magazine on Life Science business for GIT Publishing Ltd. • Held editor in chief position with responsibility for sub-editors and external content providers. Achievements Due diligence on a biosequence assets portfolio Achievements Business Intelligence Pharma Science May 29, 2004 Market monitoring for Sanofi Pasteur Achievements Business Digital Intelligence Pharma April 25, 2003 BIONEWS/Inside-Lifescience eZine published Achievements Business Digital…

Obviously, one of my most exciting projects had been establishing my own business, SCITARI – Dr. Christian Velten Informationsdienste, in 1999. Together with my team I supported life science industries with information research & analysis, digital media and market/competitor intelligence. Starting from scratch, I successively developed business with major life science market players (Roche, Aventis/Sanofi, BASF, Bayer), reputable patent law firms (e.g. Vossius), mid-sized biotechs, a German specialist publisher, and single clients form other branches of industry (e.g. Honda R&D). In parallel, I built an operative team  of internals and externals (<10) and was responsible for up to 6 associates, caring for all aspects of people management.…

Nov 1998 – Apr 1999 / LION BIOSCIENCE For supporting the IPO, I developed and implemented a new version of the corporate website. Browse CV Full CV Timeline

Today, I am proud to share that my PhD thesis with the title “Cell-cycle-dependent gene regulation by Mcm1p-complexes in Saccharomyces cerevisiae” has been accepted, and my Ph.D. (Dr. rer. nat.) has been granted by the Leibniz University of Hannover, Germany. Between 1994 and today, I had the opportunity to do basic oncological research on the genetic regulation of the cell growth at the Institute for Molecular Biology at the Hannover Medical School. I was using yeast (Saccharomyces cerevisiae) as model organism for eukaryotic cells, which on molecular level share many commonalities. My scientific research was specifically targeting a better understanding…

May 1994 – Dec 1997 / LEIBNIZ UNIVERSITY HANNOVER & HANNOVER MEDICAL SCHOOL Basic oncological research on the genetic regulation of cell growth. Scholarship for the DFG Graduate Student Course “Molecular Pathophysiology of the Cell”. Achievements PhD thesis has been accepted Achievements Science December 19, 1997 Browse CV Full CV Timeline